Dynavax Technologies
DVAX
#5000
Rank
HK$14.26 B
Marketcap
HK$121.46
Share price
0.00%
Change (1 day)
10.75%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -HK$0.27 Billion

According to Dynavax Technologies 's latest financial reports the company's current earnings are HK$0.33 Billion. In 2024 the company made an earning of HK$0.29 Billion, an increase over its 2023 earnings that were of HK$18.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.27 Billion-188.85%
2024 HK$0.29 B1475.31%
2023 HK$18.72 M-99.2%
2022 HK$2.35 B238.78%
2021 HK$0.69 B-257.89%
2020 -HK$0.45 Billion-58.58%
2019 -HK$1.07 Billion-9.32%
2018 -HK$1.18 Billion60.44%
2017 -HK$0.74 Billion-15.8%
2016 -HK$0.87 Billion4.22%
2015 -HK$0.84 Billion16.54%
2014 -HK$0.72 Billion37.09%
2013 -HK$0.53 Billion
2010 -HK$0.38 Billion214.85%
2009 -HK$0.12 Billion-37.33%
2008 -HK$0.19 Billion-66.07%
2007 -HK$0.56 Billion16.92%
2006 -HK$0.48 Billion170.36%
2005 -HK$0.18 Billion33.39%
2004 -HK$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$82.99 B-31,352.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$71.20 B-26,914.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$12.71 B-4,889.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$76.76 B-29,009.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$103.05 B-38,910.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$114.90 B-43,371.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$78.44 B-29,642.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
HK$0.16 B-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$17.79 B-6,801.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel